Publication of results of the AHA-EMI in the scientific journal "The Lancet Haematology"

A clinical trial of emicizumab shows positive results for a new treatment for acquired haemophilia A. The results have now been published in The Lancet Haematology.

How can patients with acquired haemophilia A be helped as an alternative to the complication-prone standard immunosuppressive therapy?

This question was the focus of the phase 2 clinical trial AHA-EMI, scientifically led by Prof. Andreas Tiede from Hanover and coordinated by GWT as sponsor.
The study investigated whether emicizumab, a Factor VIIIa mimetic antibody, protects patients with acquired haemophilia A from bleeding and allows the postponement of immunosuppression in the first 12 weeks after diagnosis.
The results of the AHA-EMI study show that prophylaxis with emicizumab prevents bleeding in patients with acquired haemophilia A and that immunosuppressive therapy can be postponed while this treatment is given. These results are promising for a potential new treatment option for patients with acquired haemophilia A.

Congratulations to all participating centres, patients and the entire study team on this great success.

Settings saved
Privacy Settings

We use cookies to provide you with an optimal website experience. This includes cookies that are necessary for the operation of the site and for the control of our commercial business objectives, as well as cookies that are only used for anonymous statistical purposes or for comfort settings. You can decide which categories you would like to allow. Please note that based on these settings, not all functionalities of the site may be available. Here you can find more information in our privacy policy.


Expiry: 30 days
Location: Localstorage
Description: Saves the privacy level settings from the cookie consent tool "Privacy Manager".


Expiry: 30 Tage
Location: Localstorage
Description: Saves the storage period of the privacy level settings from the cookie consent tool "Privacy Manager".


Sponsor Oversight
GWT: Your independent sponsor for comprehensive clinical trials

Clinical Project Management
Comprehensive coordination of all aspects of your clinical trial

Clinical Project Administration
Seamless communication and administration of your clinical trial

Clinical Data Management
Ensuring the highest quality and 100% integrity of your clinical data

Clinical Quality Management
Highest quality standards in the supervision of your clinical trial

GWT StudyDesigner

Transform your study design with GWT StudyDesigner - Real-time interactive design and expert advice for your clinical research!

Project Administration
Efficient administrative implementation of industrial projects

Contract Management
Individual consulting for legally compliant transfer projects

Financial Management
Ensuring and carrying out correct financial transactions

Startup Backoffice

Turn your ideas into action - supported by GWT's comprehensive business platform.

Are you ready to become entrepreneurial and focus on your product?

Take on the role of project manager and act like an entrepreneur while we support you

You are using an outdated browser. The website may not be displayed correctly. Close